Search Results - "Passmore, Linda"

Refine Results
  1. 1

    MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma by Davidson, Morgan R, Larsen, Jill E, Yang, Ian A, Hayward, Nicholas K, Clarke, Belinda E, Duhig, Edwina E, Passmore, Linda H, Bowman, Rayleen V, Fong, Kwun M

    Published in PloS one (03-09-2010)
    “…MicroRNAs (miRNAs) are a family of small, non-coding RNA species functioning as negative regulators of multiple target genes including tumour suppressor genes…”
    Get full text
    Journal Article
  2. 2

    The effect of different radiological models on diagnostic accuracy and lung cancer screening performance by Marshall, Henry M, Zhao, Henry, Bowman, Rayleen V, Passmore, Linda H, McCaul, Elizabeth M, Yang, Ian A, Fong, Kwun M

    Published in Thorax (01-12-2017)
    “…High false-positive (FP) scan rates associated with low-dose computed tomography (LDCT) lung cancer screening result in unnecessary follow-up tests and…”
    Get more information
    Journal Article
  3. 3

    Brief Tailored Smoking Cessation Counseling in a Lung Cancer Screening Population is Feasible: A Pilot Randomized Controlled Trial by Marshall, Henry M., Courtney, Deborah A., Passmore, Linda H., McCaul, Elizabeth M., Yang, Ian A., Bowman, Rayleen V., Fong, Kwun M.

    Published in Nicotine & tobacco research (01-07-2016)
    “…Maximizing smoking abstinence in lung cancer screening participants is important to reduce individual risk of disease and improve screening cost-effectiveness;…”
    Get full text
    Journal Article
  4. 4

    Cost of screening for lung cancer in Australia by Marshall, Henry M., Finn, Nicola, Bowman, Rayleen V., Passmore, Linda H., McCaul, Elizabeth M., Yang, Ian A., Connelly, Luke, Fong, Kwun M.

    Published in Internal medicine journal (01-11-2019)
    “…Background Lung cancer screening can reduce lung cancer mortality. Australian cost estimates are important to inform policy but remain uncertain. Aim To…”
    Get full text
    Journal Article
  5. 5

    Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma by LARSEN, Jill E, PAVEY, Sandra J, PASSMORE, Linda H, BOWMAN, Rayleen V, HAYWARD, Nicholas K, FONG, Kwun M

    Published in Clinical cancer research (15-05-2007)
    “…Purpose: Improving outcomes for early-stage lung cancer is a major research focus at present because a significant proportion of stage I patients develop…”
    Get full text
    Journal Article
  6. 6

    Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas by Sriram, Krishna B, Relan, Vandana, Clarke, Belinda E, Duhig, Edwina E, Windsor, Morgan N, Matar, Kevin S, Naidoo, Rishendran, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Yang, Ian A, Bowman, Rayleen V, Fong, Kwun M

    Published in BMC cancer (25-09-2012)
    “…The diagnosis of malignant pleural effusions (MPE) is often clinically challenging, especially if the cytology is negative for malignancy. DNA integrity index…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD) by Shaw, Janet G, Dent, Annette G, Passmore, Linda H, Burstow, Darryl J, Bowman, Rayleen V, Zimmerman, Paul V, Fong, Kwun M, Yang, Ian A

    Published in BMC pulmonary medicine (13-06-2012)
    “…Pulmonary hypertension (PH) is a complication of chronic obstructive pulmonary disease (COPD). This study examined genetic variations in mediators of vascular…”
    Get full text
    Journal Article
  9. 9

    Expression profiling defines a recurrence signature in lung squamous cell carcinoma by Larsen, Jill Everland, Pavey, Sandra Jane, Passmore, Linda Hazel, Bowman, Rayleen, Clarke, Belinda Edith, Hayward, Nicholas Kim, Fong, Kwun Meng

    Published in Carcinogenesis (New York) (01-03-2007)
    “…Lung cancer remains the leading cause of cancer death worldwide. Overall 5-year survival is ∼10–15% and despite curative intent surgery, treatment failure is…”
    Get full text
    Journal Article
  10. 10

    Phenotypes and karyotypes of human malignant mesothelioma cell lines by Relan, Vandana, Morrison, Leanne, Parsonson, Kylie, Clarke, Belinda E, Duhig, Edwina E, Windsor, Morgan N, Matar, Kevin S, Naidoo, Rishendran, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Yang, Ian A, Fong, Kwun M, Bowman, Rayleen V

    Published in PloS one (14-03-2013)
    “…Malignant mesothelioma is an aggressive tumour of serosal surfaces most commonly pleura. Characterised cell lines represent a valuable tool to study the…”
    Get full text
    Journal Article
  11. 11

    Lung asbestos content in lungs resected for primary lung cancer by Wright, Casey M, Bowman, Rayleen V, Tan, Maxine E, Martins, Maria U, McLachlan, Rebecca E, Passmore, Linda H, Windsor, Morgan N, Clarke, Belinda E, Duhig, Edwina E, Mahar, Annabelle M, Fong, Kwun

    Published in Journal of thoracic oncology (01-06-2008)
    “…The majority of Australia's burden of lung cancer occurs in current or former tobacco smokers. To determine the possible contribution of asbestos exposure in…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Validation of the Eighth Edition TNM Lung Cancer Staging System by Hwang, Joseph K, Page, Barbara J, Flynn, David, Passmore, Linda, McCaul, Elizabeth, Brady, Jaccalyne, Yang, Ian A, Marshall, Henry, Windsor, Morgan, Bowman, Rayleen V, Naidoo, Rishendran, Guan, Tracey, Philpot, Shoni, Blake, Michael E, Fong, Kwun M

    Published in Journal of thoracic oncology (01-04-2020)
    “…We performed a validation study at our institution, the International Union Against Cancer (Union for International Cancer Control latest version of TNM…”
    Get more information
    Journal Article
  14. 14

    Active screening for lung cancer increases smoking abstinence in Australia by Marshall, Henry M., Vemula, Mounavi, Hay, Karen, McCaul, Elizabeth, Passmore, Linda, Yang, Ian A., Bowman, Rayleen V., Fong, Kwun M.

    Published in Asia-Pacific journal of clinical oncology (01-06-2023)
    “…Background Smoking cessation is an important screening component, but the evidence base to inform implementation is lacking. We report longitudinal smoking…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Lung cancer screening feasibility in Australia by Marshall, Henry M, Bowman, Rayleen V, Ayres, John, Crossin, Jane, Lau, Melanie, Slaughter, Richard E, Redmond, Stanley, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Leong, Steven C, Windsor, Morgan, Zimmerman, Paul V, Yang, Ian A, Fong, Kwun M

    Published in The European respiratory journal (01-06-2015)
    “…The National Lung Screening Trial (NLST) reported a 20% relative reduction in lung cancer-specific mortality using low-dose computed tomography (LDCT)…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Low tumour cell content in a lung tumour bank: implications for molecular characterisation by Goh, Felicia, Duhig, Edwina E., Clarke, Belinda E., McCaul, Elizabeth, Passmore, Linda, Courtney, Deborah, Windsor, Morgan, Naidoo, Rishendren, Franz, Louise, Parsonson, Kylie, Yang, Ian A., Bowman, Rayleen V., Fong, Kwun M.

    Published in Pathology (01-10-2017)
    “…Lung cancer encompasses multiple malignant epithelial tumour types, each with specific targetable, potentially actionable mutations, such that precision…”
    Get full text
    Journal Article